Pfizer Reenters Weight Loss Arena, Wins Bidding War to Buy Metsera for $10 Billion
Pfizer has secured a $10 billion deal to acquire Metsera, a fast-rising biotech company specializing in obesity and metabolic-disease treatments, ...
Tag: Pfizer
‘The Art of the Heal’: How TrumpRx, Most-Favored Nation Pricing, Big Pharma Intersect
(The Center Square) – AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” ...
